The human gut microbiome as a screening tool for colorectal cancer

Cancer Prevention Research

Volumn 7, Issue 11, 2014, Pages 1112-1121

  Zackular, Joseph P ^a   Rogers, Mary A M ^a   Ruffin, Mack T ^a   Schloss, Patrick D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIUM; BACTEROIDES; BAYESIAN LEARNING; BODY MASS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CLOSTRIDIALES; CLOSTRIDIUM; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENTEROBACTERIACEAE; FECES; FEMALE; FUSOBACTERIUM; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LACHNOSPIRACEAE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; OCCULT BLOOD TEST; PHASCOLARCTOBACTERIUM; PORPHYROMONADACEAE; PORPHYROMONAS; PRETEST POSTTEST DESIGN; PSEUDOMONAS; RACE; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; RUMINOCOCCACEAE; RUMINOCOCCUS; TUMOR BIOPSY; TUMOR DIFFERENTIATION; ADENOMA; BAYES THEOREM; CARCINOMA; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE; PROBABILITY; PROCEDURES;

BIOLOGICAL MARKER; RNA 16S;

ADENOMA; AGED; AREA UNDER CURVE; BAYES THEOREM; BIOMARKERS; CARCINOMA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; INTESTINES; MALE; MICROBIOTA; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK FACTORS; RNA, RIBOSOMAL, 16S;

EID: 84910116215     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0129     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011;6:479-507.
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60.
4. Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2010),. released April 2013 based on the November 2012 submission ed: National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch
5. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638-58.
6. Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 2007;13:S5-18.
7. Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med 2001;16:822-30.
8. Joseph DA, King JB, Miller JW, Richardson LCCenters for Disease C, et al. Prevalence of colorectal cancer screening among adults - Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61 Suppl:51-6.
9. Howden L, Meyer J. Age and sex composition: 2010. 2010 Census Briefs: US Department of Commerce, US Census Bureau; 2012.
10. Collins JF, Lieberman DA, Durbin TE, Weiss DGVeterans Affairs Cooperative Study G. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:81-5.
11. Young GP, St John DJ, Winawer SJ, Rozen P WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507.
12. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
13. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
14. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
15. Chambers WM, Warren BF, Jewell DP, Mortensen NJ. Cancer surveillance in ulcerative colitis. Br J Surg 2005;92:928-36.
16. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125:171-80.
17. Larsson SC, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer 2005;113:829-34.
18. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
19. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
20. Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio 2013;4:e00692-13.
21. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
22. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207-15.
23. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011;6:e16393.
24. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320-9.
25. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11.
26. O'Brien CL, Allison GE, Grimpen F, Pavli P. Impact of colonoscopy bowel preparation on intestinal microbiota. PLoS ONE 2013;8:e62815.
27. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 2013;79:5112-20.
28. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: Open-source, platform-independent, com-munity- supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-41.
29. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007;35:7188-96.
30. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011;27:2194-200.
31. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261-7.
32. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
34. Isaksson A, Wallman M, Goransson H, Gustafsson MG. Cross-validation and bootstrapping are unreliable in small sample classification. Pattern Recogn Lett 2008;29:1960-5.
35. Linnet K. A review on the methodology for assessing diagnostic tests. Clin Chem 1988;34:1379-86.
36. Jeffreys H. An invariant form for the prior probability in estimation problems. Proc R Soc Lond A Math Phys Sci 1946;186:453-61.
37. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195-206.
38. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
39. Sears CL, Islam S, Saha A, Arjumand M, Alam NH, Faruque AS, et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008;47:797-803.
40. Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 2011;13:25-36.
41. Deshpande RG, Khan M, Genco CA. Invasion strategies of the oral pathogen Porphyromonas gingivalis: implications for cardiovascular disease. Invasion Metastasis 1998;18:57-69.
42. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 2010;3:149-66.
43. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-41.
44. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-73.
45. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010;107:12204-9.
46. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ, et al. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003;52:94-100.